These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 365718)

  • 21. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson-Liljeqvist B
    Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author's transl)].
    Werner H; Rintelen G; Kunstek-Santos H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):133-44. PubMed ID: 168701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W; Höffler U; Pulverer G
    Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    Clin Ther; 1990; 12 Suppl C():13-24. PubMed ID: 2390771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of anaerobic susceptibility results obtained by two methods of inoculum preparation.
    Bourgault AM; Lamothe F
    J Clin Microbiol; 1984 Dec; 20(6):1060-4. PubMed ID: 6520217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases.
    Manchanda V; Singh NP; Goyal R; Kumar A; Thukral SS
    Indian J Med Res; 2005 Oct; 122(4):330-7. PubMed ID: 16394326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibility of non-sporing anaerobes of the genera Bacteroides, Fusobacterium, Sphaerophorus, Peptococcus, and Peptostreptococcus to clindamycin (author's transl)].
    Werner H; Böhm G
    Zentralbl Bakteriol Orig A; 1974; 229(3):401-8. PubMed ID: 4155889
    [No Abstract]   [Full Text] [Related]  

  • 31. Techniques for anaerobic susceptibility testing.
    Thornsberry C
    J Infect Dis; 1977 Mar; 135 Suppl():S4-6. PubMed ID: 850089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified agar dilution method for rapid antibiotic susceptibility testing of anaerobic bacteria.
    Hanson CW; Martin WJ
    Antimicrob Agents Chemother; 1978 Mar; 13(3):383-8. PubMed ID: 400819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline.
    Sutter VL; Kwok YY; Finegold SM
    Appl Microbiol; 1972 Feb; 23(2):268-75. PubMed ID: 5017675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens.
    Goldstein EJ; Cherubin CE; Shulman M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):42-5. PubMed ID: 6338819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of anaerobic bacteria to carbenicillin.
    Blazevic DJ; Matsen JM
    Antimicrob Agents Chemother; 1974 May; 5(5):462-5. PubMed ID: 4462461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suitability of the broth-disk elution test for evaluating susceptibility of obligate anaerobes to trimethoprim-sulfonamides.
    Indiveri MC; Hirsh DC
    J Vet Diagn Invest; 1991 Jul; 3(3):215-7. PubMed ID: 1911991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.
    Appelbaum PC; Spangler SK; Jacobs MR
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):47-50. PubMed ID: 2303067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of methods for susceptibility testing of anaerobes.
    Zabransky RJ
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1025-31. PubMed ID: 1295756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation of an automated microbiology system for the growth of anaerobes and performance of antimicrobial susceptibility tests.
    Murray PR; Niles AC
    Am J Clin Pathol; 1982 Oct; 78(4):457-61. PubMed ID: 6291376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaerobic susceptibility tests: differences between disc diffusion, agar dilution and broth microdilution test results.
    Barry AL
    J Antimicrob Chemother; 1990 May; 25(5):875-7. PubMed ID: 2373671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.